Abstract

ObjectivesAortic stenosis (AS) is characterised by a long and variable asymptomatic course. Our objective was to use cardiovascular magnetic resonance imaging (MRI) to assess progression of adverse remodeling in asymptomatic AS.MethodsParticipants from the PRIMID-AS study, a prospective, multi-centre observational study of asymptomatic patients with moderate to severe AS, who remained asymptomatic at 12 months, were invited to undergo a repeat cardiac MRI.ResultsForty-three participants with moderate-severe AS (mean age 64.4 ± 14.8 years, 83.4% male, aortic valve area index 0.54 ± 0.15 cm2/m2) were included. There was small but significant increase in indexed left ventricular (LV) (90.7 ± 22.0 to 94.5 ± 23.1 ml/m2, p = 0.007) and left atrial volumes (52.9 ± 11.3 to 58.6 ± 13.6 ml/m2, p < 0.001), with a decrease in systolic (LV ejection fraction 57.9 ± 4.6 to 55.6 ± 4.1%, p = 0.001) and diastolic (longitudinal diastolic strain rate 1.06 ± 0.2 to 0.99 ± 0.2 1/s, p = 0.026) function, but no overall change in LV mass or mass/volume. Late gadolinium enhancement increased (2.02 to 4.26 g, p < 0.001) but markers of diffuse interstitial fibrosis did not change significantly (extracellular volume index 12.9 [11.4, 17.0] ml/m2 to 13.3 [11.1, 15.1] ml/m2, p = 0.689). There was also a significant increase in the levels of NT-proBNP (43.6 [13.45, 137.08] pg/ml to 53.4 [19.14, 202.20] pg/ml, p = 0.001).ConclusionsThere is progression in cardiac remodeling with increasing scar burden even in asymptomatic AS. Given the lack of reversibility of LGE post-AVR and its association with long-term mortality post-AVR, this suggests the potential need for earlier intervention, before the accumulation of LGE, to improve the long-term outcomes in AS.Key Points• Current guidelines recommend waiting until symptom onset before valve replacement in severe AS.• MRI showed clear progression in cardiac remodeling over 12 months in asymptomatic patients with AS, with near doubling in LGE.• This highlights the need for potentially earlier intervention or better risk stratification in AS.

Highlights

  • Aortic stenosis (AS) is the commonest valve lesion requiring surgery in the developed world, with increasing prevalence with ageing populations [1]

  • Several magnetic resonance imaging (MRI)-measured markers have been linked to symptoms, exercise capacity and outcome in AS, including myocardial perfusion reserve (MPR) [4, 5]; surrogate markers of diffuse interstitial fibrosis: T1, extracellular volume fraction (ECV) [6], absolute extracellular volume index [7]; and extent of focal fibrosis measured by late gadolinium enhancement (LGE) [8]

  • BMI body mass index, HR heart rate, SBP/DBP systolic/diastolic blood pressure, Hct haematocrit, ACE-I angiotensin-converting enzyme inhibitor, ARB angiotensin II receptor blocker, AV Vmax peak aortic jet velocity, MPG mean pressure gradient, AVAI aortic valve area indexed to BSA, AS aortic stenosis, LGE late gadolinium enhancement

Read more

Summary

Introduction

Aortic stenosis (AS) is the commonest valve lesion requiring surgery in the developed world, with increasing prevalence with ageing populations [1]. It is characterised by a long and variable asymptomatic course. Several MRI-measured markers have been linked to symptoms, exercise capacity and outcome in AS, including myocardial perfusion reserve (MPR) [4, 5]; surrogate markers of diffuse interstitial fibrosis: T1, extracellular volume fraction (ECV) [6], absolute extracellular volume index (iECV) [7]; and extent of focal fibrosis measured by late gadolinium enhancement (LGE) [8]. Others have shown LGE to be irreversible 1–2 years after AVR [10, 11], suggesting a need for potentially earlier intervention before LGE is established and the need for potentially reversible markers to identify those for earlier intervention

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call